文献速递乳腺MR

乳腺MRI背景实质强化与乳腺癌的相关性

Correlation of background parenchymal enhancement on breast MRI with breast cancer.
PubMed 文献 · Clin Radiol · 2023-06-02

本回顾性横断面研究纳入2007至2016年间接受乳腺MRI及组织活检的327例高危乳腺癌女性,视觉评估背景实质强化(BPE)并与年龄、纤维腺体组织、BIRADS分类、乳腺癌存在及HER2、PR、ER、Ki67表达进行相关性分析。结果显示BPE与乳腺癌无显著相关性,左右乳之间无差异,BPE可能不是乳腺癌发生的可靠生物标志物。

要点

  • BPE与纤维腺体组织仅呈弱相关,右乳r=-0.14、左乳r=0.16,对判断背景强化程度帮助有限。
  • BPE与年龄呈弱负相关,右乳r=-0.14、左乳r=-0.15,提示年龄越大背景强化可能越低。
  • BPE与乳腺癌无显著相关性,且左右乳之间无差异,不宜将BPE作为乳腺癌发生的可靠生物标志物。

核心结论

  • BPE与乳腺癌无显著相关性,左右乳之间无显著差异,BPE可能不是乳腺癌发生的可靠生物标志物。

研究设计与样本

  • 回顾性横断面研究,纳入327例连续患者(平均年龄60岁,范围30-90岁),2007至2016年间接受乳腺MRI及组织活检,所有MRI图像(T1、T2及减影图像)均采用视觉评估。

关键影像表现/征象

  • BPE与纤维腺体组织呈弱相关,右乳r=-0.14、p=0.004,左乳r=0.16、p=0.003。
  • BPE与患者年龄呈弱负相关,右乳r=-0.14、p=0.007,左乳r=-0.15、p=0.006。
  • 右乳BPE与HER2显著相关(p=0.02),左乳BPE与HER2的相关性不显著。
  • BPE与BIRADS分类的相关性中,仅右乳BPE与右乳BIRADS显著相关(p=0.031)。

临床应用与阅片要点

  • 原文结论提示BPE与乳腺癌无显著相关性,左右乳之间无显著差异。
  • 原文认为BPE可能不是乳腺癌发生的可靠生物标志物。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To evaluate the prognostic value of background parenchymal enhancement (BPE) in breast magnetic resonance imaging (MRI) in women referred to radiological department as a high risk for breast cancer.

MATERIALS AND METHODS: A retrospective, cross-sectional study included 327 consecutive patients (mean age: 60 years, age range: 30-90 years) who underwent breast MRI and tissue biopsy between 2007 and 2016. All MRI images (T1, T2, and subtraction images) were evaluated visually. The relationship of BPE with patient age, fibroglandular tissue (FGT), Breast Imaging Reporting and Data System (BIRADS) categories, presence of breast cancer, and expression of human epidermal growth factor receptor 2 (HER2), progesterone receptor (PR), oestrogen receptor (ER), and Ki67 were analysed. Furthermore, all variables were correlated with pre- and postmenopausal status.

RESULTS: BPE of bilateral breast showed a weak correlation with FGT (right BPE: r=-0.14, p=0.004; left BPE: r=0.16, p=0.003), a weak negative correlation with patient age (right BPE: r=-0.14, p=0.007; left BPE: r=-0.15, p=0.006), and significant correlation with HER2 (right BPE, p=0.02), left BPE with HER2 was not significant. Among the correlations between BPE and BIRADS, only between right BPE and right BIRADS was significant (p=0.031). No clear evidence of an association between breast MRI BPE and breast cancer in premenopausal and postmenopausal status was observed, and no difference was found between the right and left breasts.

CONCLUSIONS: The results of the present study showed no significant correlations between BPE and breast cancer. In addition, there was no significant difference between the right and left breast. Hence, BPE of MRI may not be a reliable biomarker of breast cancer development.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Sallam, Lenga, Solbach, et al. Correlation of background parenchymal enhancement on breast MRI with breast cancer. Clin Radiol. 2023. PMID: 37330320. doi:10.1016/j.crad.2023.05.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。